148 related articles for article (PubMed ID: 25371625)
1. A bone fide atypical fibroxanthoma of penis.
Cuomo R; Addesso M; Altieri R; D'Antonio A
Urol Ann; 2014 Oct; 6(4):381-3. PubMed ID: 25371625
[TBL] [Abstract][Full Text] [Related]
2. Malignant fibrous histiocytoma of the glans penis: a case report.
Katona TM; Shienbaum AJ; Wyatt LL; Brown GA; Cheng L
Anal Quant Cytol Histol; 2006 Feb; 28(1):39-42. PubMed ID: 16566278
[TBL] [Abstract][Full Text] [Related]
3. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
5. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
6. Clear cell atypical fibroxanthoma: a case report and review of the literature.
Nguyen CM; Chong K; Cassarino D
J Cutan Pathol; 2016 Jun; 43(6):538-542. PubMed ID: 26956561
[TBL] [Abstract][Full Text] [Related]
7. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
8. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma, rare and often unrecognized cutaneous soft tissue tumor - a case report and review of the literature.
Čierna Z; Trška R
Cesk Patol; 2019; 55(3):182-186. PubMed ID: 31726845
[TBL] [Abstract][Full Text] [Related]
10. Clear cell atypical fibroxantoma: a rare variant of atypical fibroxanthoma and review of the literature.
Bedir R; Agirbas S; Sehitoglu I; Yurdakul C; Elmas O
J Clin Diagn Res; 2014 Jun; 8(6):FD09-11. PubMed ID: 25120992
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma.
Sakamoto A
Clin Med Oncol; 2008; 2():117-27. PubMed ID: 21892274
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid Carcinoma With Quasi-Complete Loss of Cytokeratin Expression or Keratin-Positive Atypical Fibroxanthoma.
Roy SF; Lafaille P; Désy D
Int J Surg Pathol; 2019 Aug; 27(5):518-520. PubMed ID: 30760056
[TBL] [Abstract][Full Text] [Related]
15. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
16. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
Wieland CN; Dyck R; Weenig RH; Comfere NI
J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
[TBL] [Abstract][Full Text] [Related]
17. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Is superficial infiltration in subcutaneous tissue acceptable in AFX?
van Midden D; Flucke UE; Amir AL; Bonenkamp JJ; Lubeek SFK; Blokx WAM
Ann Diagn Pathol; 2022 Jun; 58():151915. PubMed ID: 35276548
[TBL] [Abstract][Full Text] [Related]
18. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic dermal sarcoma: it might be rare but it exists.
Seretis K; Klaroudas A; Galani V; Papathanakos G; Varouktsi A; Mitselou A; Batistatou A; Lampri E
J Surg Case Rep; 2023 Aug; 2023(8):rjad374. PubMed ID: 37545789
[TBL] [Abstract][Full Text] [Related]
20. Atypical fibroxanthoma-a diagnosis of exclusion!
Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]